Buildit, obviously for pure accounting purposes, t
Post# of 36537
(Total Views: 368)
Posted On: 01/08/2021 5:43:29 PM
Buildit, obviously for pure accounting purposes, the full 400,300,000 NGIO shares must be considered. I was just thinking in terms how a $5/share value could be rationalized.
Speaking of investor valuation, GNBT should now be valued at $4.37/share. That number should be posted on every stock evaluation website!
MATH:
($)500,000,000(NGIO valuation) / 400,300,000(NGIO shares) = $1.249(share)
($)1.249 x 364,003,151(GNBT held shares) = $454,639,935
$454,639,935 + $26,396,157(current cap) = $481,036,092
($)481,036,092 / 109,983,989(GNBT shares) = $4.37(share)
Speaking of investor valuation, GNBT should now be valued at $4.37/share. That number should be posted on every stock evaluation website!
MATH:
($)500,000,000(NGIO valuation) / 400,300,000(NGIO shares) = $1.249(share)
($)1.249 x 364,003,151(GNBT held shares) = $454,639,935
$454,639,935 + $26,396,157(current cap) = $481,036,092
($)481,036,092 / 109,983,989(GNBT shares) = $4.37(share)
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼